Buradasınız

Anasayfa » Content

Acil Serviste Pulmoner Tromboemboli Tanısı Alan Hastaların Retrospektif Olarak Değerlendirilmesi

Retrospective Evaluation of Patients Diagnosed With Pulmonary Thromboembolism in the Emergency Department

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2009

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Aim: Pulmonary thromboembolism (PTE) is a major health problem. The aim of this study was the retrospective evaluation of patients diagnosed with pulmonary thromboembolism in the emergency department with regard to underlying risk factors, diagnostic procedures, treatment modalities, mortality rates and mortality-related factors. Materials and method: Two hundred and five patients, that were treated between 2004 and 2007, were retrospectively evaluated. Demographic characteristics of the patients were analyzed together with underlying risk factors, diagnostic procedures, treatment modalities, mortality rates and mortality-related factors. Results: With regard to risk factors, gynecological surgical interventions were present in 17 patients, orthopedical surgical interventions in 58, abdominal surgical interventions in 20, intracranial surgical interventions in 12, comorbid disorders in 25, history of immobility in 20, antiphospolipid antibody positivity in five, protein C and protein S defficiency in five and oral contraceptive use in three, whereas no risk factors could be observed in 35 patients. Sixteen patients had a mortal disease course. Conclusion: PTE is a life threatening disorder and early recognition is important. In the postoperative period, appropriate medical measures and the prophylactic administration of low molecular weight heparin might prevent the development of deep vein thrombosis and, hence, PTE.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Pulmoner tromboemboli (PTE) önemli bir sağlık sorunudur. Bu çalışmada, acil serviste PTE tanısı alan hastaların altta yatan risk faktörleri, tanı yöntemleri, tedavi yöntemleri, mortalite oranları ve mortaliteye neden olan faktörler açısından retrospektif olarak değerlendirilmesi amaçlanmıştır. Materyal ve metot: 2004 ile 2007 yılları arasında tedavi uygulanan 205 hasta retrospektif olarak değerlendirildi. Hastaların demografik özellikleri ile altta yatan risk faktörleri, uygulanan tanı yöntemleri, uygulanan tedavi yöntemleri, mortalite oranları ve mortaliteye neden olan faktörler incelendi. Bulgular: Risk faktörü olarak hastaların 18’inde jinekolojik cerrahi girişim, 59’unda ortopedik cerrahi girişim, 20’sinde abdominal cerrahi girişim, 12’sinde intrakranial cerrahi girişim, 25’inde komorbid hastalıklar, 20’sinde immobilite öyküsü, beşinde antifosfolipid antikor pozitifliği, beşinde protein C ve protein S eksikliği ve üçünde oral kontraseptif kullanım öyküsü mevcutken 38 hastada herhangi bir risk faktörüne rastlanmamıştı. Onaltı hastada hastalık mortal seyretmişti. Sonuç: PTE yaşamı tehdit eden bir hastalıktır ve erken tanınması önemlidir. Postoperatif dönemde gerekli medikal önlemlerin alınması ve düşük molekül ağırlıklı heparin profilaksisi ile derin venöz trombüs ve PTE oluşumunun önüne geçilebilir.
FULL TEXT (PDF): 
PDF icon arastirmax-acil-serviste-pulmoner-tromboemboli-tanisi-alan-hastalarin-retrospektif-olarak-degerlendirilmesi.pdf
  • 4
233-236
  • Turkish

REFERENCES

References: 

1. British Thoracic Society. Suspected acute pulmonary embolism: a
practical approach. Thorax 1997; 52:S1–S24.
2. PIOPED Investigators. Value of the ventilation-perfusion lungs
can in acute pulmonary embolism. JAMA 1990; 263:2753-9.
3. Fedullo PF, Morris TA.Disorders of the pulmonary circulation.
In: Mason RJ, Murray JF, Broaddus VC, Madel JA, editors
Murray and Nadel’s Textbook of Respiratory Medicine 4th
edition Elsevier-Saunders Philadelphia 2005; 1425-79.
4. Dalen JE, Alpert JS. Natural history of pulmonary embolism.
Prog Cardiovasc Dis 1975; 17:259-70.
5. Ryu JH, Olson EJ, Pellikka PA. Clinical recognition of
pulmonary embolism: problem of unrecognized and
asymptomatic cases. Mayo Clin Proc 1998; 73:873-9.
6. Robetoyre RS, Rodgers GM. Update on selected inherited
venous thrombotic disorders. Am J Hematol 2001; 68:256-68.
7. Hirsh J, Bates SM. Prognosis in acute pulmonary embolism.
Lancet 1999; 353:1375-6.
8. Prandoni P, ten Cate JW. Epidemiology, risk factors, and natural
history of venous thromboembolism. In: Oudkerk M, van Beek
EJR, ten Cate JW, eds. Pulmonary embolism, diagnosis and
treatment. Berlin: Blackwell; 1999; 2-34.
9. Anderson FA Jr., Wheeler HB, Goldberg RJ, et al. A populationbased
perspective of the hospital incidence and case-fatality rates
of deep vein thrombosis and pulmonary embolism. The
Worcester DVT Study. Arch Intern Med 1991; 151:933-8.
10. Nordstrom M, Lindblad B, Bergqvist D, et al. A prospective
study of the incidence of deep-vein thrombosis within a defined
urban population. J Intern Med 1992; 232:155-60.
11. Jamieson SW, Auger WR, Fedullo PF, Channick RN, Kriett JM,
Tarazi RY, et al. Experience and results with 150 pulmonary
thromboendarterectomy operations over a 29-month period. J
Thorac Cardiovasc Surg 1993; 106:116-27.
12. Kroegel C, Reissig A. Principle mechanisms underlying venous
thromboembolism: epidemiology, risk factors, pathophysiology
and pathogenesis. Respiration. 2003; 70:7-30.
13. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen
GL. The risk of a diagnosis of cancer after primary deep venous
thrombosis or pulmonary embolism. New Engl J Med 1998;
338:1169-73.
14. Michota F. Venous thromboembolism: epidemiology,
characteristics, and consequences. Clin Cornerstone 2005; 7:8-15.
15. Heit JA. Venous thromboembolism: disease burden, outcomes
and risk factors. J Thromb Haemost 2005; 3:1611-7.
16. Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients
with solid tumors: Determination of frequency and
characteristics. Thromb Haemost 2002; 87:575-9.
17. Otten HM, Mathijssen J, ten Cate H, et al. Symptomatic venous
thromboembolism in cancer patients treated with chemotherapy:
an underestimated phenomenon. Arch Intern Med 2004;
164:190-4.
18. Kızkın Ö, Hacıevliyagil SS, Günen H. Yatan hastalarda
tromboemboli profilaksinin klinik önemi. İnönü Üniversitesi Tıp
Fakültesi Dergisi 2004; 11: 155-9.

Thank you for copying data from http://www.arastirmax.com